Authors
Loading...
Randomized trial identifies a signature predicting survival in acute myeloid leukemia, suggesting new therapeutic targets.
Gan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: